Core Viewpoint - Rosen Law Firm has announced a class action lawsuit against Varonis Systems, Inc. for allegedly misleading investors about its business operations and annual recurring revenue projections during the specified class period from February 4, 2025, to October 28, 2025 [1][2]. Allegations - The lawsuit claims that Varonis provided investors with overly positive statements regarding its expected annual recurring revenue (ARR) for the 2025 fiscal year, expressing confidence in its ability to maintain ARR projections while transitioning existing customers to a software-as-a-service (SaaS) model [3]. - It is alleged that Varonis concealed material adverse facts about its capability to convert its existing customer base to the SaaS offering, which led to inflated security prices and ultimately caused shareholder losses when the truth was revealed [4]. Next Steps - Shareholders interested in participating in the class action must file motions to serve as lead plaintiffs by March 9, 2026. They can choose to remain absent class members without participating in the case [5]. Law Firm Background - Rosen Law Firm specializes in securities class actions and has a track record of recovering over $1 billion for shareholders, emphasizing its commitment to improving corporate governance and holding executives accountable [7].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Varonis (VRNS) To Contact Him Directly To Discuss Their Options If you purchased or acquired Varonis’ common stock between February 4, 2025, and October 28, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- What’s Happenin ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Varonis Systems, Inc. ("Varonis†or the "Company†) (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, inclusive (the "Class Period†). Varonis investors have until March 9, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VARONIS SYSTEMS, INC. (VRNS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO ...

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: Defendants provided overwhelmingly positive statements to investors while, at the ...

ATLANTA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Varonis Systems, Inc. (NASDAQ: VRNS). The lawsuit alleges that Defendants issued false and misleading statements concerning Varonis’ ability to convert its existing customer base and its ARR growth potential in the near-term. If you purchased Varonis shares between February 4, 2025, and October 28, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by ...

Core Viewpoint - The Varonis Systems, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims that the company misrepresented its revenue outlook and growth potential, leading to significant stock price declines following disappointing financial results [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Molchanov v. Varonis Systems, Inc., and it involves purchasers of Varonis common stock between February 4, 2025, and October 28, 2025 [1]. - Investors have until March 9, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Varonis and its executives created a false impression of the company's financial health, particularly regarding its annual recurring revenue growth and the effectiveness of its sales strategies [3]. Group 2: Financial Performance - On October 28, 2025, Varonis reported third-quarter results that significantly missed prior projections, leading to a lowered full-year guidance [4]. - The CEO, Yakov Faitelson, attributed the shortfall to lower renewals in both the Federal vertical and the non-Federal on-prem subscription business during the final weeks of the quarter [4]. - Following the announcement of these results, Varonis's stock price fell nearly 49% [4]. Group 3: Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Varonis common stock during the class period to seek appointment as lead plaintiff [5]. - The lead plaintiff is typically the investor with the greatest financial interest in the case and acts on behalf of all class members [5]. - Investors can choose their own legal representation for the class action lawsuit, and participation as lead plaintiff does not affect the ability to share in any potential recovery [5]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [6]. - The firm has been ranked 1 in the ISS Securities Class Action Services rankings for four out of the last five years [6]. - Robbins Geller is recognized for obtaining some of the largest securities class action recoveries in history, including a record $7.2 billion in the Enron case [6].

Plaintiff alleges that on October 28, 2025, defendants released third quarter results below prior projections and lowered their full-year guidance. On this news, the price of Varonis' common stock declined from $63.00 per share on October 28, 2025, to $32.34 per share on October 29, 2025, a decline of about 48.67% in the span of just a single day. SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Varonis ...

NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock of Varonis Systems, Inc. (“Varonis” or the “Company”) (NASDAQ: VRNS) between February 4, 2025, and October 28, 2025, inclusive. You are hereby notified that the class action lawsuit Artem Molchanov v. Varonis Systems, Inc., et al. (Case No. 1:26-cv-00117) has been commenced in the United States District Court for the Southe ...

Upgrades - Argus upgraded BHP Group (BHP) to Buy from Hold with a price target of $68, citing firming prices for iron ore, copper, and coal as the global economy improves [1] Downgrades - Jefferies downgraded Mereo BioPharma (MREO) to Hold from Buy with a price target of $0.50, down from $7, due to Setrusumab missing primary endpoints in trials [2] - RBC Capital downgraded DigitalBridge (DBRG) to Sector Perform from Outperform with a price target of $16, down from $23, following SoftBank's acquisition announcement at $16 per share [3] Initiations - Stephens initiated coverage of Commvault (CVLT) with an Overweight rating and a $162 price target, highlighting its evolution in data protection and transition to Software-as-a-Service [4] - Stephens initiated coverage of Rubrik (RBRK) with an Overweight rating and a $105 price target, noting its attractive growth outlook in data protection and data security [4] - Stephens initiated coverage of Varonis (VRNS) with an Equal Weight rating and a $40 price target, emphasizing its growth potential in data security as a Software-as-a-Service platform [4] - Freedom Capital initiated coverage of Ero Copper (ERO) with a Buy rating and a $32 price target, citing its high-grade, low-cost asset portfolio in Brazil [4] - H.C. Wainwright initiated coverage of Terra Innovatum (NKLR) with a Buy rating and a $25 price target, believing its use of off-the-shelf components will reduce regulatory barriers [4]

Upgrades - Argus upgraded BHP Group (BHP) to Buy from Hold with a price target of $68, citing firming prices for iron ore, copper, and coal as the global economy improves [2] Downgrades - Jefferies downgraded Mereo BioPharma (MREO) to Hold from Buy with a price target of 50 cents, down from $7, due to Setrusumab missing primary endpoints in trials, impacting Mereo's future strategy [3] - RBC Capital downgraded DigitalBridge (DBRG) to Sector Perform from Outperform with a price target of $16, down from $23, following SoftBank's acquisition announcement at $16 per share, totaling a $4 billion enterprise value [4] Initiations - Stephens initiated coverage of Commvault (CVLT) with an Overweight rating and a $162 price target, highlighting its leadership in data protection and transition to Software-as-a-Service [5] - Stephens initiated coverage of Rubrik (RBRK) with an Overweight rating and a $105 price target, noting its strong growth outlook in data protection and expected margin expansion [5] - Stephens initiated coverage of Varonis (VRNS) with an Equal Weight rating and a $40 price target, emphasizing its growth potential in data security as a Software-as-a-Service platform [5] - Freedom Capital initiated coverage of Ero Copper (ERO) with a Buy rating and a $32 price target, pointing out its high-grade, low-cost assets in Brazil [5] - H.C. Wainwright initiated coverage of Terra Innovatum (NKLR) with a Buy rating and a $25 price target, believing its use of off-the-shelf components will lower regulatory and technological barriers [5]